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WHOOPING CRANE TITERS TO EASTERN EQUINE ENCEPHALITIS VACCINATIONS
GLENN H. OLSEN, USGS Patuxent Wildlife Research Center, 12302 Beech Forest Road, Laurel, MD 20708
ERIN KOLSKI, Eleanor Roosevelt High School, Greenbelt, MD
JEFF S. HATFIELD, USGS Patuxent Wildlife Research Center, 12100 Beech Forest Road, Laurel, MD 20708
DOUGLAS E. DOCHERTY, USGS National Wildlife Health Center, 6006 Schroeder Road, Madison, WI 53711
Abstract: In 1984 an epizootic of eastern equine encephalitis (EEE) virus killed 7 of 39 (18%) whooping cranes in captivity at
the Patuxent Wildlife Research Center in Laurel, Maryland, USA. Since that time whooping cranes have been vaccinated with a
human EEE vaccine. This vaccine was unavailable for several years, necessitating use of an equine vaccine in the cranes. This
study compared the antibody titers measured for three years using the human vaccine with those measured for two years using the
equine form. Whooping cranes developed similarly elevated titers in one year using the human vaccine and both years using the
equine vaccine. However, in two years where the human vaccine was used, the whooping cranes developed signiﬁcantly lower
titers compared to other years.
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The objective of this study was to compare antibody titer
levels observed in years when the human vaccine was used with
the 2 years when the equine vaccine was used. When an equine
vaccine was ﬁrst tested in the 1980’s, the titer levels were lower
than those seen with the human vaccine (Clark et al. 1987), and
we wanted to discover if this was still true with the currently
available equine vaccine.

Eastern Equine Encephalitis (EEE) is a clinically important
disease of horses, people, and some birds including whooping
cranes (Grus americana). EEE is classiﬁed as a zoonotic vectorborne alpha virus. The virus is found in eastern North America
and is maintained and ampliﬁed by a mosquito-wild bird cycle.
Native wild passerines carry the virus and initiate the cycle,
with viremic birds being found 37-51 days before virus is ﬁrst
detected in mosquitoes beginning in July or August and lasting
through October (Crans et al. 1994). The virus is then spread
by the mosquitoes and ampliﬁed in the hatch-year passerines.
EEE does not typically produce morbidity or mortality in native
passerines, but has been known to cause mortality in non-native
birds (pheasants, emus; Tengelsen 2001), horses, bats (Main
1979), and humans.
Vaccination as a tool to control arbovirus infections in
horses is a widespread practice that provides effective protection (American Association of Equine Practitioners, 1995; Tenglesen et al. 2001). Commercially available equine vaccines
for EEE are used to protect emus from the disease (Tengelson
et al. 2001). Between September 17 and December 5, 1984 an
epizootic of EEE killed 7 of 39 captive whooping cranes at
the Patuxent Wildlife Research Center, Laurel, Maryland USA
(Dein et al. 1986, Carpenter et al. 1989). Following the 1984
EEE epizootic at Patuxent, all whooping cranes began receiving annual injections of EEE vaccine (Clark et al. 1987; Olsen et al. 1997). There were no challenge studies done with the
endangered whooping cranes. Naturally occurring epizootics
were documented in sentinel birds and in mosquitoes, with no
morbidity or mortality in captive whooping cranes. This led
to the conclusion that the vaccination program was efﬁcacious
(Olsen et al. 1997). In 2000 and 2001, the human EEE vaccine
previously used was not available for the whooping cranes at
Patuxent. As an alternative; the birds were vaccinated with a
commercially available equine vaccine.

METHODS
All adult whooping cranes housed at Patuxent were kept
in 15 x 20 m outdoor pens. Very young whooping crane chicks
being costume-reared for release programs spent the ﬁrst 7-10
days conﬁned indoors in 3 x 3 m pens, but afterwards were in
indoor/outdoor pens until 40-50 days of age, after which time
they were housed totally outside.
All whooping crane chicks received their ﬁrst injection of
EEE vaccine in July. For 1989-1999 this was 0.5 ml intramuscular injection of the PE 6 WRAIR strain human EEE vaccine
(The Salk Institute, Government Service Division, Swiftwater,
Pennsylvania, USA). This was followed 1 month later by an intramuscular injection of 1.0 ml. Yearly revaccination using the
same 1.0 ml dose of the PE 6 WRAIR EEE vaccine occurred
in late August or early September, to coincide with the seasonal
peak of activity (August-October) for the EEE carrying mosquito (Culiseta melanura) at Patuxent (Pagac et al, 1992).
In 2000 and 2001, all adult whooping cranes received a
1.0 ml intramuscular dose of Encephaloid M (EEE and western equine encephalitis vaccine, Fort Dodge Laboratories, Fort
Dodge, Iowa USA) in August of each year. All whooping crane
chicks received the same Encephaloid M as 0.5 ml intramuscularly in July and 1.0 ml intramuscularly in August of their hatch
year.
Blood samples to obtain serum for titers were collected
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in late October or early November of each year during routine health examinations of the whooping cranes. Serum was
shipped frozen to the USGS National Wildlife Health Center,
Madison, Wisconsin, USA for analysis by hemaglutinationinhibition testing (HI, 1994-1997) or by serum neutralization
testing (SN, 2000-2001) at the National Veterinary Services
Laboratory, Ames, Iowa, USA. We analyzed the EEE titers for
1994, 1996 and 1997, years in which the human vaccine was
used, and the most recent years (2000, 2001) when the equine
vaccine was used. Due to budget constraints, no titers had been
tested in 1995, 1998 or 1999.
Data were analyzed with a repeated measure analysis of
variance (ANOVA) using a compound symmetry model in the
mixed-models procedure of SAS (Statistical Analysis System,
Version 6.12; 1997). The subject factor was crane identiﬁcation
number nested with gender. Prior to analysis, titers were transformed with a log 10 transformation to help achieve normality
and homoscedasticity of residuals. Pairwise comparisons were
performed on the least square means using a Tukey multiple
comparison procedure (P < 0.05).
RESULTS AND DISCUSSION
Antibody titers were available from a total of 52 whooping
cranes for the years 1994-1997 (human vaccine) and 2000-2001
(equine vaccine). For the 3 years when the human vaccine was
used, the titers were highly variable (Table 1). The titers for
1994 were very low, while the 1996 titers were high, equivalent to those found with the equine vaccine. The 1997 titers
were higher than 1994 but lower than 1996. Table 1 shows the
untransformed means, sample sizes, and standard deviations,
as well as pairwise comparison results of the log-transformed
least square means. The mean titers for 1996, 2000, and 2001
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were not signiﬁcantly different (P > 0.05) from each other. The
titer means for 1994 and 1997 were signiﬁcantly different from
each other and were different from 1996, 2000, 2001 EEE mean
titers (P < 0.05). We used two different tests to determine the
titers (HI and SN) but saw no differences in titer levels in 1996
(HI), 2000 or 2001 (SN). Titers seen with the human vaccine
were considered protective due to the absence of morbidity or
mortality seen in whooping cranes in years since 1984 when
EEE was detected in mosquitoes and sentinel birds (Olsen et
al. 1997). The equine vaccine tested produced titers equal to or
higher than those produced by the human vaccine, which would
suggest adequate protection.
Initial testing of a commercially available equine EEE vaccine and the Salk human EEE vaccine in the 1980’s had shown
superior titer levels when using the human vaccine (Clark et.
al, 1987). Therefore, the decision was made to vaccinate the
captive whooping cranes with the human vaccine. Unavailability of this vaccine starting in 2000 prompted the switch to an
equine form of EEE vaccine. These results show that the titers
obtained from this new equine EEE vaccine equal or exceed the
titers seen with the human EEE vaccine used in the past. The
human vaccine continues to be unavailable today, and, given
current world events, it is unlikely to be released by the military
any time soon. Therefore, continued use of an equine EEE vaccine appears to be an appropriate management tool to prevent
this disease in captive whooping cranes.
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Table 1. Geometric mean, sample size, standard error, and Tukey’s multiple comparison
test of eastern equine encephalitis virus antibody titers measured in whooping cranes
(Grus americana) at Patuxent Wildlife Research Center, Laurel, Maryland USA, 19942001.

Year
1994
1996
1997
2000
2001

Sample Size (n) Geometric Mean
33
39
37
52
51

6.08
88.13
15.07
81.23
82.64

Standard Error
1.22
1.21
1.21
1.19
1.19

Tukey’s testa
A
B
C
B
B

Means with the same letter are not signiﬁcantly different (P > 0.05), based on
Tukey’s multiple comparison procedure of the least square means generated from
the log-transformed titer levels in the repeated measures ANOVA.

a

9:2005

Proc. North Am. Crane Workshop

9:2005

EASTERN EQUINE ENCEPHALITIS TITIERS · Olsen et al.

NWHC, especially Renee Long and Kristina Egstad. We also
thank the USAMRIID, Fort Detrick, Fredrick Maryland, USA
for supplying us with the SALK human EEE vaccine used at
Patuxent for the protection of the whooping cranes throughout
the 1990’s.
LITERATURE CITED
Carpenter, J. W, G. G. Clark, and D. M. Watts. 1989. The
impact of eastern equine encephalitis virus on efforts to
recover the endangered whooping crane. Technical Publication No. 10, International Council for Bird Preservation, Cambridge, UK. Pages 115-120
Clark, G. G., F. J. Dein, C. L. Crabbs, J. W. Carpenter, and D.
M. Watts. 1987. Antibody response of sandhill and
whooping cranes to an eastern equine encephalitis virus
vaccine. Journal of Wildlife Diseases 23:539-544.
Council on Biology and Therapeutic Agents. 1995. Guidelines for vaccination of horses. Journal of the American
Veterinary Medical Association, 207:426-430.
Crans, W. J, D. F. Caccamise, and J. R. McNelly. 1994. Eastern equine encephalomyelitis virus in relation to the avian
community of a coastal cedar swamp. Journal of Medical

23

Entomology 31(5):711-728
Dein, F. J, J. W Carpenter, G. G. Clark, R. J. Montali, C. L.
Crabbs, T. F. Tsai, and D. E. Docherty. 1986. Mortality
of captive whooping cranes caused by eastern equine encephalitis virus. Journal of the American Veterinary Medical Association, 189:1006-1010.
Main, A. J. 1979. Eastern equine encephalomyelitis virus in
experimentally infected bats. Journal of Wildlife Diseases, 15(3):467-477
Olsen, G. H., M. J. Turell, and B. B. Pagac. 1997. Efﬁcacy of
eastern equine encephalitis immunization in whooping
cranes. Journal of Wildlife Diseases 33(2):312-315.
Pagac, B. B., M. J. Turell, and G. H. Olsen. 1992. Eastern
equine encephalomyelitis virus and Culiseta melanura activity at the Patuxent Wildlife Research Center, 1985-90.
Journal of the American Mosquito Control Association,
8(3):328-330.
Tengelsen, L. A., R. A. Bowen, M. A. Royals, G. L. Campbell,
N. Komar, and R. B. Craven. 2001. Response to and efﬁcacy of vaccination against eastern equine encephalomyelitis virus in emus. Journal of the American Veterinary
Medical Association, 218:1469-1473.

24

Proc. North Am. Crane Workshop

9:2005

